Why you can’t miss PSA21

With a diverse program of clinical, therapeutic and industry sessions for pharmacists in all practice settings, PSA21 will help grow your medicines expertise.

TGA changes continue to impact and sometimes baffle pharmacists

A number of recent decisions by the Therapeutic Goods Administration (TGA) are highly relevant to pharmacists in Australia. Firstly, the interim decision from the...

How pharmacists can support patients with dementia

Nicola Sander MPS, a dementia support pharmacist in regional South Australia, will share her experience at PSA25 in August.

SSRIs for mild cognitive impairment to Alzheimer’s disease

Could selective serotonin reuptake inhibitors (SSRIs) help reduce the burden of Alzheimer’s disease and prevent decline from mild cognitive impairment? An estimated 10% of people...

Pharmacist on the rise

Ayomide Ogundipe’s initiative, commitment to patient-centred care, and leadership while interning at Pharmacy777 in Perth has earned her PSA’s Intern of the Year award. Ms...

Research winners for PSA18

Researchers examining polypharmacy within aged populations have won the best paper and best poster categories at PSA18. Lauren Corre and a team of University of...